STAT+: Pharmalittle: We’re reading about obesity drug sales, India’s biopharma research push, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of deadlines, online meetings, and phone calls has predictably returned. But what can you do? The …